Parexel International is widening its presence in Nottingham, U.K., tapping local grant funds to consolidate some outposts with plans to grow around its latest acquisition.
The list of life science data projects underpinned by Google keeps getting longer. Having signed up to the BRAIN Initiative last week, Google has now teamed up with ISB and SRA International to work on a project for the National Cancer Institute.
Researchers at the University of California, Davis, have solved a century-old mystery by discovering that the bluetongue virus that affects cattle and sheep survives winter by reproducing in midges, which spread the virus.
Novartis has expanded its relationship with the U.K.'s Oxford BioMedica, signing a deal worth up to $90 million that will support the drugmaker's efforts in CAR-T immunotherapies.
Isis Pharmaceuticals has kicked off a Phase III trial on ISIS-SMNrx, a treatment for the rare spinal muscular atrophy, moving forward with the orphan drug as partner Biogen Idec considers whether to take the plunge on the program.
A robotic prosthetic controlled by implanted neuromuscular interfaces has been demonstrated to be clinically successful in a patient for the first time. The researchers expect to treat more patients with novel technology this year. The results are reported in the latest issue of Science Translational Medicine.
It's one step back, one step forward for AstraZeneca's key respiratory drug benralizumab.
Biotech R&D is on a roll. For the third year in a row, the life sciences group at BDO has tracked a spike in R&D spending at a wide swath of public biotechs in the U.S. For drug developers with $50 million to $300 million in revenue, research budgets swelled 28%--to an average of $137 million--last year.
Startup CoheroHealth, developer of the AsthmaHero app and spirometer for measuring the volume of air inhaled and exhaled by the lungs, will test its solution on 50 patients at New York City's Mount Sinai Medical Center.
The weightless microgravity environment of space can alter disease-causing bacteria as they grow--and that's not necessarily a bad thing.